blog

FDA Regulations for Software as a Medical Device (SaMD) in the United States

Software as a Medical Device (SaMD) refers to standalone software intended to be used for one or more medical purposes (e.g., diagnosis, screening, monitoring, mitigation, treatment, or alleviation of disease) without being part of a hardware medical device. This includes mobile apps, AI/ML-based diagnostic tools, cloud-based imaging analysis software, clinical decision support systems, and other […]

FDA Regulations for Software as a Medical Device (SaMD) in the United States Read More »

CDSCO Regulations for Software as a Medical Device (SaMD) in India

Software as a Medical Device (SaMD) refers to standalone software intended to perform one or more medical purposes (e.g., diagnosis, monitoring, prediction, prevention, or treatment of disease) without being part of or embedded in a hardware medical device. This includes mobile apps, AI/ML-based diagnostic tools, cloud-based imaging analysis software, and other digital health solutions running

CDSCO Regulations for Software as a Medical Device (SaMD) in India Read More »

Form MD-26 Details: Application for Permission to Import or Manufacture Novel Medical Devices in India

Manufacture Novel Medical Devices – Under the Medical Devices Rules, 2017 (MDR 2017), Form MD-26 is the prescribed application form submitted to the Central Licensing Authority (CLA) within the Central Drugs Standard Control Organisation (CDSCO). It is used to seek prior permission for importing or manufacturing a novel (new or investigational) medical device that does

Form MD-26 Details: Application for Permission to Import or Manufacture Novel Medical Devices in India Read More »

MD-26 Explained: Application Form for Permission to Import or Manufacture Novel (New) Medical Devices in India

MD-26 Explained – Under the Medical Devices Rules, 2017 (MDR 2017), Form MD-26 is the official application form submitted to the Central Licensing Authority (CLA) of the Central Drugs Standard Control Organisation (CDSCO) when seeking permission to import or manufacture a novel medical device (also called an investigational medical device or new medical device). A

MD-26 Explained: Application Form for Permission to Import or Manufacture Novel (New) Medical Devices in India Read More »

CDSCO Import License for Medical Device Manufacturing in India 2026: Full Process, Fees & Documents Required

Importing medical devices into India for manufacturing, assembly, or further processing requires a CDSCO Import License (Form MD-15), even if the goal is local production. Under the Medical Devices Rules, 2017 (with 2025–2026 updates on perpetual validity, retention fees, and streamlined submissions), foreign manufacturers must appoint an Indian Authorized Agent to apply via the SUGAM

CDSCO Import License for Medical Device Manufacturing in India 2026: Full Process, Fees & Documents Required Read More »

MHRA Approval Process: Overview for Medicines and Medical Devices in the UK (2026)

The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s independent regulator for medicines, medical devices, blood components, and related products. Post-Brexit, the MHRA operates a distinct UK framework (separate from the EU/EMA), focusing on Great Britain (England, Wales, Scotland) and Northern Ireland (with some EU alignment via the Windsor Framework). The MHRA emphasizes

MHRA Approval Process: Overview for Medicines and Medical Devices in the UK (2026) Read More »

EMA Drug Approvals: Key Process, Timelines & Comparison to FDA

The European Medicines Agency (EMA) is the centralized regulatory body for the European Union (EU), responsible for evaluating and recommending approvals for human medicines across 27 EU member states plus Iceland, Liechtenstein, and Norway (EEA). EMA’s process focuses on harmonized evaluation, but final marketing authorization comes from the European Commission (EC), adding a step not

EMA Drug Approvals: Key Process, Timelines & Comparison to FDA Read More »

CDSCO vs FDA Medical Device Approvals: Key Differences in Classification, Pathways, and Requirements

The Central Drugs Standard Control Organisation (CDSCO) in India and the U.S. Food and Drug Administration (FDA) both regulate medical devices using risk-based systems to ensure safety and effectiveness. While aligned on core principles, differences in stringency, timelines, clinical data requirements, and post-market oversight make dual-market strategies essential for manufacturers. As of 2026, CDSCO continues

CDSCO vs FDA Medical Device Approvals: Key Differences in Classification, Pathways, and Requirements Read More »

CDSCO manufacturing license process 2026

The CDSCO manufacturing license process for medical devices in India is governed by the Medical Devices Rules, 2017 (with ongoing updates and amendments through 2026). The Central Drugs Standard Control Organisation (CDSCO) oversees approvals, primarily through its online SUGAM portal (cdscomdonline.gov.in). Licensing depends on the device’s risk classification (Class A to D), with State Licensing

CDSCO manufacturing license process 2026 Read More »

CDSCO Medical Device Import License: Essential Forms, Step-by-Step Procedure & Key Requirements in 2026

The Central Drugs Standard Control Organisation (CDSCO) regulates the import of medical devices into India under the Medical Devices Rules, 2017 (with ongoing amendments as of 2026, including updates on perpetual validity for licenses subject to retention fees and pathways for subsequent importers). The required forms depend on whether the device is “existing” (notified with

CDSCO Medical Device Import License: Essential Forms, Step-by-Step Procedure & Key Requirements in 2026 Read More »